1. "Take up to eight tablets per day": Incorporating free‐text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Issue 6 (11th February 2023) Authors: Jani, Meghna; Yimer, Belay Birlie; Selby, David; Lunt, Mark; Nenadic, Goran; Dixon, William G. Journal: Pharmacoepidemiology and drug safety Issue: Volume 32:Issue 6(2023) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 201 Anxiety, occupation and functional ability at the start of treatment and EULAR response are the main predictors of work outcomes in patients with rheumatoid arthritis commencing either methotrexate or biologics. (12th April 2019) Authors: Gwinnutt, James; Leggett, Sarah; Lunt, Mark; Barton, Anne; Hyrich, Kimme; Walker-Bone, Karen; Verstappen, Suzanne Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 212 Multimorbidity is associated with increased disability but lower disease activity over time in patients with RA: results from the BSRBR-RA. (25th April 2018) Authors: Humphreys, Jenny; Watson, Kath; Lunt, Mark; Symmons, Deborah; Hyrich, Kimme Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 234 The effect of a low versus high first prescribed dose of methotrexate on EULAR response at six months using data from the RAMS study. (25th April 2018) Authors: Davies, Rebecca; Lunt, Mark; Barton, Anne; Hyrich, Kimme L; Verstappen, Suzanne Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 243 Long‐term risk of serious infections in patients with rheumatoid arthritis treated with rituximab: five year data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR‐RA). (25th April 2018) Authors: De Cock, Diederik; Kearsley-Fleet, Lianne; Silva-Fernandez, Lucia; Lunt, Mark; Watson, Kath; Symmons, Deborah; Hyrich, Kimme Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A comparison of methods for estimating the temporal change in a continuous variable: Example of HbA1c in patients with diabetes. Issue 12 (15th August 2017) Authors: Sheppard, Therese; Tamblyn, Robyn; Abrahamowicz, Michal; Lunt, Mark; Sperrin, Matthew; Dixon, William G. Journal: Pharmacoepidemiology and drug safety Issue: Volume 26:Issue 12(2017) Page Start: 1474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phased approach to unlocking during the COVID‐19 pandemic—Lessons from trend analysis. Issue 8 (19th May 2020) Authors: Stedman, Mike; Davies, Mark; Lunt, Mark; Verma, Arpana; Anderson, Simon G.; Heald, Adrian H. Journal: International journal of clinical practice Issue: Volume 74:Issue 8(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A randomised trial of a brace for patellofemoral osteoarthritis targeting knee pain and bone marrow lesions. Issue 6 (16th January 2015) Authors: Callaghan, Michael J; Parkes, Matthew J; Hutchinson, Charles E; Gait, Andrew D; Forsythe, Laura M; Marjanovic, Elizabeth J; Lunt, Mark; Felson, David T Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 6(2015) Page Start: 1164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk. Issue 1 (3rd October 2013) Authors: Yarwood, Annie; Han, Buhm; Raychaudhuri, Soumya; Bowes, John; Lunt, Mark; Pappas, Dimitrios A; Kremer, Joel; Greenberg, Jeffrey D; Plenge, Robert; Worthington, Jane; Barton, Anne; Eyre, Steve Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 1(2015) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0434 EARLY EXPERIENCE WITH JAK INHIBITOR PRESCRIBING IN THE UK: RESULTS FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER FOR RHEUMATOID ARTHRITIS (BSRBR-RA). (June 2019) Authors: Page, Jennifer; Kearsley-Fleet, Lianne; Davies, Rebecca; Watson, Kath; Hyrich, Kimme; Lunt, Mark Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗